CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion President and CEO acquired 78,100 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President and CEO bought 1,069,290 shares at $0.47 ($500,000)
- 4 Grant or award President and CEO acquired 517,116 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 317,379 shares (grant or award)
- 4 Grant or award Director acquired 126,951 shares (grant or award)
- 4 Grant or award President and CEO acquired 317,379 shares (grant or award)
- 4 Grant or award SVP and General Counsel acquired 63,475 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 14 of 23 · 459 filings